ACHL
Price
$1.48
Change
+$0.01 (+0.68%)
Updated
Mar 20 closing price
Capitalization
63.22M
4 days until earnings call
Ad is loading...

ACHL

Header iconACHL Comparison
Open Charts ACHLBanner chart's image
Achilles Therapeutics
Price$1.48
Change+$0.01 (+0.68%)
Volume$1.2M
Capitalization63.22M
ACHL Comparison Chart
Loading...
View a ticker or compare two or three
Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ACHL: $1.48)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHL’s FA Score shows that 2 FA rating(s) are green while.

  • ACHL’s FA Score: 2 green, 3 red.

Price Growth

ACHL (@Biotechnology) experienced а 0.00% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +15.24%, and the average quarterly price growth was -12.41%.

Reported Earning Dates

ACHL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ACHL
Capitalization63.2M
EBITDA-67.33M
Gain YTD29.825
P/E RatioN/A
Revenue0
Total Cash86.1M
Total Debt3.62M
TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X103241.4600006209.140600
+6.40%
Bitcoin cryptocurrency
TSLA284.828.60
+3.11%
Tesla
GME26.780.77
+2.96%
GameStop Corp
SPY565.063.91
+0.70%
SPDR® S&P 500® ETF
AAPL197.491.24
+0.63%
Apple

ACHL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHL has been loosely correlated with SCNI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHL jumps, then SCNI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHL
1D Price
Change %
ACHL100%
N/A
SCNI - ACHL
45%
Loosely correlated
N/A
SNPX - ACHL
43%
Loosely correlated
+1.67%
MDGL - ACHL
34%
Loosely correlated
+0.25%
EWTX - ACHL
33%
Loosely correlated
+1.24%
CYTK - ACHL
32%
Poorly correlated
-1.69%
More